Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen

Interaction of Fas and Fas ligand (FasL) plays an important role in the regulation of immune responses by inducing apoptosis of activated cells; however, a possible role of FasL in DNA vaccination has not been well understood. We examined whether administration of DNA encoding FasL gene enhanced ant...

Full description

Saved in:
Bibliographic Details
Main Authors: Boya Zhong, Guangyu Ma, Ayako Sato, Osamu Shimozato, Hongdan Liu, Quanhai Li, Masato Shingyoji, Yuji Tada, Koichiro Tatsumi, Hideaki Shimada, Kenzo Hiroshima, Masatoshi Tagawa
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2015/743828
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551324916383744
author Boya Zhong
Guangyu Ma
Ayako Sato
Osamu Shimozato
Hongdan Liu
Quanhai Li
Masato Shingyoji
Yuji Tada
Koichiro Tatsumi
Hideaki Shimada
Kenzo Hiroshima
Masatoshi Tagawa
author_facet Boya Zhong
Guangyu Ma
Ayako Sato
Osamu Shimozato
Hongdan Liu
Quanhai Li
Masato Shingyoji
Yuji Tada
Koichiro Tatsumi
Hideaki Shimada
Kenzo Hiroshima
Masatoshi Tagawa
author_sort Boya Zhong
collection DOAJ
description Interaction of Fas and Fas ligand (FasL) plays an important role in the regulation of immune responses by inducing apoptosis of activated cells; however, a possible role of FasL in DNA vaccination has not been well understood. We examined whether administration of DNA encoding FasL gene enhanced antitumor effects in mice that were vaccinated with DNA expressing a putative tumor antigen gene, β-galactosidase (β-gal). Growth of β-gal-positive Colon 26 tumors was retarded in the syngeneic mice immunized with β-gal and FasL DNA compared with those vaccinated with β-gal or FasL DNA. We did not detect increased numbers of β-gal-specific CD8+ T cells in lymph node of mice that received combination of β-gal and FasL DNA, but amounts of anti-β-gal antibody increased with the combination but not with β-gal or FasL DNA injection alone. Subtype analysis of anti-β-gal antibody produced by the combination of β-gal and FasL DNA or β-gal DNA injection showed that IgG2a amounts were greater in mice injected with both DNA than those with β-gal DNA alone, but IgG2b amounts were lower in both DNA-injected than β-gal DNA-injected mice. These data suggest that FasL is involved in boosting humoral immunity against a gene product encoded by coinjected DNA and enhances the vaccination effects.
format Article
id doaj-art-7dcaed6ba6ba47ef992fc40ad3086d0b
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-7dcaed6ba6ba47ef992fc40ad3086d0b2025-02-03T06:01:44ZengWileyJournal of Immunology Research2314-88612314-71562015-01-01201510.1155/2015/743828743828Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor AntigenBoya Zhong0Guangyu Ma1Ayako Sato2Osamu Shimozato3Hongdan Liu4Quanhai Li5Masato Shingyoji6Yuji Tada7Koichiro Tatsumi8Hideaki Shimada9Kenzo Hiroshima10Masatoshi Tagawa11Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050035, ChinaDepartment of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050035, ChinaDivision of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba 260-8717, JapanDivision of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba 260-8717, JapanDivision of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba 260-8717, JapanDivision of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba 260-8717, JapanDepartment of Thoracic Diseases, Chiba Cancer Center, Chiba 260-8717, JapanDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, JapanDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, JapanDepartment of Surgery, School of Medicine, Toho University, Tokyo 143-8541, JapanDepartment of Pathology, Tokyo Women’s Medical University Yachiyo Medical Center, Yachiyo 276-8524, JapanDivision of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba 260-8717, JapanInteraction of Fas and Fas ligand (FasL) plays an important role in the regulation of immune responses by inducing apoptosis of activated cells; however, a possible role of FasL in DNA vaccination has not been well understood. We examined whether administration of DNA encoding FasL gene enhanced antitumor effects in mice that were vaccinated with DNA expressing a putative tumor antigen gene, β-galactosidase (β-gal). Growth of β-gal-positive Colon 26 tumors was retarded in the syngeneic mice immunized with β-gal and FasL DNA compared with those vaccinated with β-gal or FasL DNA. We did not detect increased numbers of β-gal-specific CD8+ T cells in lymph node of mice that received combination of β-gal and FasL DNA, but amounts of anti-β-gal antibody increased with the combination but not with β-gal or FasL DNA injection alone. Subtype analysis of anti-β-gal antibody produced by the combination of β-gal and FasL DNA or β-gal DNA injection showed that IgG2a amounts were greater in mice injected with both DNA than those with β-gal DNA alone, but IgG2b amounts were lower in both DNA-injected than β-gal DNA-injected mice. These data suggest that FasL is involved in boosting humoral immunity against a gene product encoded by coinjected DNA and enhances the vaccination effects.http://dx.doi.org/10.1155/2015/743828
spellingShingle Boya Zhong
Guangyu Ma
Ayako Sato
Osamu Shimozato
Hongdan Liu
Quanhai Li
Masato Shingyoji
Yuji Tada
Koichiro Tatsumi
Hideaki Shimada
Kenzo Hiroshima
Masatoshi Tagawa
Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen
Journal of Immunology Research
title Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen
title_full Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen
title_fullStr Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen
title_full_unstemmed Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen
title_short Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen
title_sort fas ligand dna enhances a vaccination effect by coadministered dna encoding a tumor antigen through augmenting production of antibody against the tumor antigen
url http://dx.doi.org/10.1155/2015/743828
work_keys_str_mv AT boyazhong fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen
AT guangyuma fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen
AT ayakosato fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen
AT osamushimozato fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen
AT hongdanliu fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen
AT quanhaili fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen
AT masatoshingyoji fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen
AT yujitada fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen
AT koichirotatsumi fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen
AT hideakishimada fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen
AT kenzohiroshima fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen
AT masatoshitagawa fasliganddnaenhancesavaccinationeffectbycoadministereddnaencodingatumorantigenthroughaugmentingproductionofantibodyagainstthetumorantigen